Hot Jobs

Looking for Career in Pharmacovigilance/ Clinical Research. Enter details here.

Sunday, 24 August 2014

Safety Associate II @ inVentive Health Clinical, Pune

Organization Overview:

inVentiv Health Clinical, formerly PharmaNet/i3, is a leading provider of global drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies. With 7,000 employees in more than 36 countries, inVentiv Health Clinical offers therapeutically specialized capabilities for all phases of clinical development, bioanalytical services, and strategic resourcing.

Title

Responsibilities

Review serious adverse experience (SAE) information received from Investigator sites and adverse experiences (AEs) from post marketing sources for completeness and regulatory compliance

Prepare safety data reports for submissions to clients

Prepare expedited Safety Reports for submission to Regulatory Authorities

Assist in representation of Global Safety and Pharmacovigilance group at project team and client meetings

Communicate with Clinical Operations and clients to ensure compliance with safety and pharmacovigilance SOPs

Assist in compilation of regulatory submissions, i.e., Annual Reports, Periodic Safety Update Reports

Assist the safety lead for projects; to include set-up, project management, client liaison

Perform literature searches

Assist with SAE reconciliation

Maintain current knowledge of all applicable FDA/EU/ICH guidelines and regulations relating to safety and pharmacovigilance reporting

Requirements

Candidate should have 2-3 years of experience in Pharmacovigillance with core case processing experience. ARGUS database experience preferred

Bachelors / master’s degree preferably in pharmacy, life science, Ayurveda medicine (allied medicine), MSc (Microbiology, biotechnology).

Local Candidates will be preferred.

Possess good communication skills

City Pune

Country India [IN]

Read More





from Trinity Publishing House http://ift.tt/1vbqlfz

via IFTTT

No comments:

Post a Comment

Subscribe to us